BIOCRYST PHARMACEUTICALS INC·4

Jun 2, 4:32 PM ET

HEGGIE THERESA 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 2, 2023

Insider Transaction Report

Form 4
Period: 2023-05-31
Transactions
  • Award

    Common Stock

    2023-05-31$8.27/sh+680$5,62432,369 total
Footnotes (1)
  • [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT